Sign Out
No formal interaction studies with Praxbind and other medicinal products have been performed. Based on the pharmacokinetic properties and the high specificity in binding to dabigatran, clinically relevant interactions with other medicinal products are considered unlikely.
Preclinical investigations have shown no interactions with volume expanders, coagulation factor concentrates and anticoagulants other than dabigatran (see Pharmacology: Pharmacodynamics under Actions).
